PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
IVVD vs. OCUP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IVVD and OCUP is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

IVVD vs. OCUP

Last updated Jun 1, 2025

Compare and contrast key facts about Invivyd Inc. (IVVD) and Ocuphire Pharma, Inc. (OCUP).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IVVD or OCUP.

Performance

IVVD vs. OCUP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invivyd Inc. (IVVD) and Ocuphire Pharma, Inc. (OCUP). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

IVVD:

$112.16M

OCUP:

$31.74M

EPS

IVVD:

-$1.19

OCUP:

-$0.54

PS Ratio

IVVD:

3.06

OCUP:

1.93

PB Ratio

IVVD:

2.07

OCUP:

0.93

Total Revenue (TTM)

IVVD:

$36.69M

OCUP:

$1.11M

Gross Profit (TTM)

IVVD:

$34.24M

OCUP:

$832.00K

EBITDA (TTM)

IVVD:

-$145.63M

OCUP:

-$8.33M

Returns By Period

IVVD

YTD

111.01%

1M

54.04%

6M

33.84%

1Y

-49.18%

3Y*

-31.90%

5Y*

N/A

10Y*

N/A

OCUP

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Invivyd Inc.

Ocuphire Pharma, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

IVVD vs. OCUP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
IVVD
The Risk-Adjusted Performance Rank of IVVD is 4747
Overall Rank
The Sharpe Ratio Rank of IVVD is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of IVVD is 7474
Sortino Ratio Rank
The Omega Ratio Rank of IVVD is 6969
Omega Ratio Rank
The Calmar Ratio Rank of IVVD is 2020
Calmar Ratio Rank
The Martin Ratio Rank of IVVD is 3131
Martin Ratio Rank
OCUP
The Risk-Adjusted Performance Rank of OCUP is 77
Overall Rank
The Sharpe Ratio Rank of OCUP is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of OCUP is 55
Sortino Ratio Rank
The Omega Ratio Rank of OCUP is 77
Omega Ratio Rank
The Calmar Ratio Rank of OCUP is 1111
Calmar Ratio Rank
The Martin Ratio Rank of OCUP is 66
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IVVD vs. OCUP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invivyd Inc. (IVVD) and Ocuphire Pharma, Inc. (OCUP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

IVVD vs. OCUP - Dividend Comparison

Neither IVVD nor OCUP has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

IVVD vs. OCUP - Drawdown Comparison

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

IVVD vs. OCUP - Volatility Comparison

Loading data...

Financials

IVVD vs. OCUP - Financials Comparison

This section allows you to compare key financial metrics between Invivyd Inc. and Ocuphire Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.0010.00M20.00M30.00M40.00MJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
11.30M
1.11M
(IVVD) Total Revenue
(OCUP) Total Revenue
Values in USD except per share items